Through analysis, we found that USP45 is closely related to the infiltration level of tumor killer cells such as NK cells, macrophages, and dendritic cells in the tumor microenvironment, as well as immune checkpoints such as PD-L1, suggesting that USP45 can be used as a target of tumor immunotherapy to enhance the effect of tumor immunotherapy. The gene discussed is CD274; the disease is neoplasm.